Market Capitalization of Beta Drugs (BETA)
As of July 24, 2026, Beta Drugs (BETA) market capitalisation is ₹2346.39 Cr ($260.71M), with 1.01 Cr shares outstanding at a current price of ₹2315.60 on NSE, ranking 1126 out of 5363 companies by market cap in our screener. Beta Drugs operates in the Healthcare sector and is classified as a Small Cap stock. View BETA 52-week performance for the annual high/low range and current price position.
Market Cap History of Beta Drugs (Last 10 Years)
BETA market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Beta Drugs share price chart.
End of Year Market Cap History — Beta Drugs
BETA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with BETA DCF valuation to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2346.39 Cr
$260.71M USD
|
₹2315.60 | NSE | +49.48% |
| 2025 |
₹1569.70 Cr
$174.41M USD
|
₹1549.10 | NSE | - |